183 related articles for article (PubMed ID: 25491117)
1. Inner Ear Vestibular Signals Regulate Bone Remodeling via the Sympathetic Nervous System.
Vignaux G; Ndong JD; Perrien DS; Elefteriou F
J Bone Miner Res; 2015 Jun; 30(6):1103-11. PubMed ID: 25491117
[TBL] [Abstract][Full Text] [Related]
2. Bone remodeling is regulated by inner ear vestibular signals.
Vignaux G; Besnard S; Ndong J; Philoxène B; Denise P; Elefteriou F
J Bone Miner Res; 2013 Oct; 28(10):2136-44. PubMed ID: 23553797
[TBL] [Abstract][Full Text] [Related]
3. The Vestibular System: A Newly Identified Regulator of Bone Homeostasis Acting Through the Sympathetic Nervous System.
Vignaux G; Besnard S; Denise P; Elefteriou F
Curr Osteoporos Rep; 2015 Aug; 13(4):198-205. PubMed ID: 26017583
[TBL] [Abstract][Full Text] [Related]
4. Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system.
Kondo H; Nifuji A; Takeda S; Ezura Y; Rittling SR; Denhardt DT; Nakashima K; Karsenty G; Noda M
J Biol Chem; 2005 Aug; 280(34):30192-200. PubMed ID: 15961387
[TBL] [Abstract][Full Text] [Related]
5. Sympathetic neural influence on bone metabolism in microgravity (Review).
Mano T; Nishimura N; Iwase S
Acta Physiol Hung; 2010 Dec; 97(4):354-61. PubMed ID: 21138811
[TBL] [Abstract][Full Text] [Related]
6. The vestibular system is critical for the changes in muscle and bone induced by hypergravity in mice.
Kawao N; Morita H; Obata K; Tamura Y; Okumoto K; Kaji H
Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27697847
[TBL] [Abstract][Full Text] [Related]
7. Absence of substance P and the sympathetic nervous system impact on bone structure and chondrocyte differentiation in an adult model of endochondral ossification.
Niedermair T; Kuhn V; Doranehgard F; Stange R; Wieskötter B; Beckmann J; Salmen P; Springorum HR; Straub RH; Zimmer A; Grifka J; Grässel S
Matrix Biol; 2014 Sep; 38():22-35. PubMed ID: 25063231
[TBL] [Abstract][Full Text] [Related]
8. Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.
Fonseca TL; Jorgetti V; Costa CC; Capelo LP; Covarrubias AE; Moulatlet AC; Teixeira MB; Hesse E; Morethson P; Beber EH; Freitas FR; Wang CC; Nonaka KO; Oliveira R; Casarini DE; Zorn TM; Brum PC; Gouveia CH
J Bone Miner Res; 2011 Mar; 26(3):591-603. PubMed ID: 20814988
[TBL] [Abstract][Full Text] [Related]
9. Central control of bone remodeling by neuromedin U.
Sato S; Hanada R; Kimura A; Abe T; Matsumoto T; Iwasaki M; Inose H; Ida T; Mieda M; Takeuchi Y; Fukumoto S; Fujita T; Kato S; Kangawa K; Kojima M; Shinomiya K; Takeda S
Nat Med; 2007 Oct; 13(10):1234-40. PubMed ID: 17873881
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption.
Togari A; Arai M
J Pharmacol Sci; 2008 Apr; 106(4):542-6. PubMed ID: 18431037
[TBL] [Abstract][Full Text] [Related]
11. Role of follistatin in muscle and bone alterations induced by gravity change in mice.
Kawao N; Morita H; Obata K; Tatsumi K; Kaji H
J Cell Physiol; 2018 Feb; 233(2):1191-1201. PubMed ID: 28471505
[TBL] [Abstract][Full Text] [Related]
12. [Neuromediators and neurotransmitters in the bone tissue remodeling].
Aviakosm Ekolog Med; 2012; 46(2):3-8. PubMed ID: 22953533
[TBL] [Abstract][Full Text] [Related]
13. Sympathetic B antagonist prevents bone mineral density decrease induced by labyrinthectomy.
Denise P; Besnard S; Vignaux G; Sabatier JP; Edy E; Hitier M; Levasseur R
Aviakosm Ekolog Med; 2009; 43(6):36-8. PubMed ID: 20169738
[TBL] [Abstract][Full Text] [Related]
14. Role of saposin C and D in auditory and vestibular function.
Lustig LR; Alemi S; Sun Y; Grabowski G; Akil O
Laryngoscope; 2016 Feb; 126(2):452-9. PubMed ID: 26198053
[TBL] [Abstract][Full Text] [Related]
15. The role of the sympathetic nervous system in controlling bone metabolism.
Togari A; Arai M; Kondo A
Expert Opin Ther Targets; 2005 Oct; 9(5):931-40. PubMed ID: 16185149
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.
Bonnet N; Pierroz DD; Ferrari SL
J Musculoskelet Neuronal Interact; 2008; 8(2):94-104. PubMed ID: 18622078
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis: a neuroskeletal disease?
Takeda S
Int J Biochem Cell Biol; 2009 Mar; 41(3):455-9. PubMed ID: 18761104
[TBL] [Abstract][Full Text] [Related]
18. Altered auditory and vestibular functioning in individuals with low bone mineral density: a systematic review.
Singh NK; Jha RH; Gargeshwari A; Kumar P
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):1-10. PubMed ID: 29043479
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis.
Onodera S; Sasaki S; Ohshima S; Amizuka N; Li M; Udagawa N; Irie K; Nishihira J; Koyama Y; Shiraishi A; Tohyama H; Yasuda K
J Bone Miner Res; 2006 Jun; 21(6):876-85. PubMed ID: 16753018
[TBL] [Abstract][Full Text] [Related]
20. Different sympathetic pathways control the metabolism of distinct bone envelopes.
Bataille C; Mauprivez C; Haÿ E; Baroukh B; Brun A; Chaussain C; Marie PJ; Saffar JL; Cherruau M
Bone; 2012 May; 50(5):1162-72. PubMed ID: 22326888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
